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mal karyotype, retained the APOE4/4 genotype, expressed pluripotency markers, were free of genomically inte-
grated plasmids, and could be differentiated into cell type representatives from the three germ layers in vitro.
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The generation of human IPSC line i11001 was carried out using E8
based media and feeder-free conditions. EBV-transformed B-lympho-
cyte cells from a 79-year old Alzheimer's Disease (AD) patient, generat-
ed by Coriell Institute For Medical Research, were employed. The
patient had a history of progressive presenile dementia, with a parent
and three siblings of the patient also being affected (iPSC line i10984).eg).
. This is an open access article underThe patient was homozygous for the APOE4 allele. This was conﬁrmed
by a PCR-RFLP assay (Hixson and Vernier, 1990) carried out with the
lymphoblastoid cell line (Fig. 1A).
The lymphoblastoid cells (LCs) were electroporated with OriP/
EBNA-1 based episomal plasmids expressing reprogramming factors
OCT4, SOX2, KLF-4, L-MYC, LIN28 and a p53 shRNA (Okita et al.,
2011). The APOE4/4 genotype of the generated iPS line was conﬁrmed
by sequencing (Fig. 1A). After several passages, a PCR for episomal vec-
tor backbone conﬁrmed that exogenous episomal factors were not
being expressed anymore (Fig. 1A).
i11001 iPSC colonies displayed a typical ES-like colony morphology
(Fig. 1B). Immunocyto-chemical analysis revealed expressionof transcrip-
tion factors OCT4 and SOX2, and surface markers SSEA4 and TRA-1-81,
characteristic of pluripotent stem cells (Fig. 1B). The iPS cells exhibited a
normal karyotype (46, XX) by G-Banding analysis (Fig. 1B). The cells
also demonstrated differentiation capacity to three germ layers using an
embryoid body-based directed differentiation protocol, followed by im-
munostaining with markers corresponding to the three germ layers i.e.
ectoderm (PAX6), mesoderm (FOXC1) and endoderm (GATA4) (Fig. 1C).
Materials and methods
Cell culture
The LC line was cultured in RPMI-1640 Medium (Gibco™) supple-
mented with 15% FBS (MP Biomedicals), 1% Penicillin/Streptomycin
(Invitrogen™) and 1% GlutaMAX (Invitrogen™) at 37 °C and 5% CO2.
Derivation of the iPS cell line and expansion
LCs were reprogrammed by electroporating 200,000 cells with OriP/
EBNA-1-based episomal plasmids (the plasmids were a gift from Shinyathe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Generation and characterization of i11001 line. (A) Conﬁrmation of APOE4/4 status of
lymphoblastoid (source) line and i11001 iPS line by PCR-RFLP assay and Sanger sequencing,
respectively. (Sequencing trace is reverse complement of sense strand). Product of OriP and
EBNA PCR runwith a positive control, shows episomal plasmids have been lost by the iPSCs.
(B) i11001 cellular morphology resembles ES-like cell morphology. Immunoﬂuorescence
staining for pluripotency markers OCT4, SOX2, SSEA4, TR-A1-81 is positive. Karyotype is
normal (46, XX). Scale bar: 100 μm (C) EB formation was induced, followed by directed
differentiation to, and immunoﬂuorescence staining for markers of, the three germ layers:
Ectoderm: PAX6, Mesoderm: FOXC1, Endoderm: GATA4. Scale bar: 100 μm.
Table 1
Antibodies used for immunocytochemistry.
Antibody
Pluripotency Markers Rabbit anti-OCT4
Rabbit anti-SOX2
Mouse anti-SSEA4
Mouse anti-TRA-1-81
Differentiation Markers Rabbit anti-FOXC1
Rabbit anti-GATA4
Mouse anti-PAX6
Secondary antibodies CF488A Goat Anti-Mouse IgG (H + L)
CF488A Goat Anti-Rabbit IgG (H + L)
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p53 (Okita et al., 2011) using a Neon transfection system (Invitrogen™).
1 μg of each plasmid and 10 ul tip of the Neon microporator kit were
used for 2 pulses of 30 ms each at 1100 V. The cells were plated on
Matrigel (Corning®) coated plates, in E8 medium without TGF-β, sup-
plemented with 100 µM sodium butyrate. After 15–17 days, colonies
started to appear and when they reached a sufﬁcient size, were manu-
ally picked and plated onto Matrigel (Corning®) coated plates, in com-
plete E8 medium. Cells were passaged by exposing to DPBS (without
Ca++ & Mg++) for a few minutes, then scraping the cell aggregates
with a scraper, followed by mechanical trituration and subculturing.
Cells were frozen using CryoStor® (Sigma-Aldrich).
Polymerase chain reaction
PCR for OriP and EBNA-1 was carried out using primers as described
in Cai et al. (2015). PCR reaction was performed using Kapa HiFi Poly-
merase (Kapa Biosystems) with cycling conditions: 94 °C for 30 s,
55 °C for 30 s, 72 °C for 1 min for 35 cycles. Episomal vector pCXLE-
hUL was used as a positive control. The products were run on a 2% aga-
rose gel.
Genotyping of APOE sequence
PCR of APOE exon 4 was carried out using the primers:
Forward: 5′CAGTCTCTCACACTCGTCCTGGC3′; Reverse: 5′CTGCTCCT
TCACCTCGTCCA3′ PCR reaction was performed using Kapa HiFi Poly-
merase (Kapa Biosystems) with cycling conditions: 94 °C for 30 s,
61 °C for 30 s, 72 °C for 1 min for 30 cycles.
Sanger sequencing was then performed on the PCR product using
the reverse primer by Euroﬁns Genomics.
APOE genotyping by RFLP assay
Genotyping for APOE status of the LCs was carried out by PCR ampli-
ﬁcation followed by HhaI digestion as described in Hixson and Vernier
(1990). An APOE3/4 line DNA was run as a reference.
Karyotyping
Karyotyping of the iPS cells was performed as described in Campos et
al. (2009), followed byG-Banding.Metaphaseswere imaged using a Zeiss
Axioskop, 60×, and analysed using Ikaros software (Metasystems). At
least 30 metaphases were counted.
Embryoid body (EB) formation and directed differentiation
For EB formation, iPSC colonies were ﬁrst dissociated to single cells
using Accutase® (Sigma-Aldrich), counted and cultured, hanging asDilution Company (Cat #)
1:300 Cell Signalling Technology #9656
1:300 Cell Signalling Technology #9656
1:300 Cell Signalling Technology #9656
1:300 Cell Signalling Technology #9656
1:100 Bethyl Laboratories Inc. #A303-520 A
1:200 Bethyl Laboratories Inc. #A303-503 A
1:100 Developmental Studies Hybridoma Bank #AB 528427
1:1000 Biotium Inc. #20010
1:1000 Biotium Inc. #20019
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plemented with 4 mg/ml polyvinyl alcohol.
For differentiation into germ layer precursors, small molecules were
used as described in Frank et al. (2012). Brieﬂy, for differentiation to
neuroectoderm, 5 days of treatment with FTDAmedium supplemented
with 0.5mMPD0325901, 15mMSB431542 and 0.5mMDorsomorphin
was applied. For mesodermal differentiation, treatment for 2 days with
10 ng/ml FGF2, 5 ng/ml Activin A, 10 ng/ml BMP4 (R&D), and 5 mM
CHIR99021 was carried out. Endodermal differentiation was induced by
treatment with 10 ng/ml FGF2, 100 ng/ml Activin A, 10 ng/ml BMP4,
and 5 mM CHIR99021 for 1d, and then with 100 ng/ml Activin A for
3 days. Following this treatment, plated cells were immunostained.
Immuno cytochemistry
Expression of pluripotency and germ layer markers was veriﬁed
using immunocytochemical staining on cells plated on coverslips. Cells
were ﬁxed in 4% PFA (15 min, room temperature (RT)), permeabilized
(with the exception of surface markers) with 0.1 M Glycine and 0.25%
triton in PBS (10min, RT). This was followed by blocking in 30% normal
goat serum (1 h, RT) and incubation with primary (overnight, 4 °C) and
secondary (1 h, RT) antibodies (see Table 1) in 2% BSA/PBS. Nuclei werestained using 1 μg/ml DAPI (1 h, RT). Cells were imaged using a Leica
DMI6000 B.
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